# reload+after+2024-01-19 21:44:09.657892
address1§19805 North Creek Parkway
city§Bothell
state§WA
zip§98011
country§United States
phone§305 425 1780
website§https://www.cocrystalpharma.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington.
fullTimeEmployees§12
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Roger D. Kornberg Ph.D.', 'age': 76, 'title': 'Co-Founder, Chairman of the Board, Chief Scientist & Chairman of Scientific Advisory Board', 'yearBorn': 1947, 'fiscalYear': 2022, 'totalPay': 125000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Sam  Lee Ph.D.', 'age': 63, 'title': 'Co-Founder, Co-CEO & President', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 521384, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. James J. Martin CPA, M.B.A.', 'age': 56, 'title': 'Co-CEO, CFO & Corporate Secretary', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 521384, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.264
currency§USD
dateShortInterest§1702598400
forwardEps§-2.36
exchange§NCM
quoteType§EQUITY
shortName§Cocrystal Pharma, Inc.
longName§Cocrystal Pharma, Inc.
firstTradeDateEpochUtc§1329921000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§5d5b1348-0247-3919-af78-0964a6c68948
gmtOffSetMilliseconds§-18000000
targetHighPrice§10.0
targetLowPrice§5.0
targetMeanPrice§8.33
targetMedianPrice§10.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§3
quickRatio§15.742
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
